ROBERT BOWERS

Head of Global Commercial Strategy

Rob is Head of Global Commercial Strategy with a focus on product and portfolio strategy, pricing and market access, digital, data and analytics, and digital health innovation - to help make HIV a smaller part of people's lives.

Rob began his biopharmaceutical career at GSK in 2000 where he built deep operational expertise in the UK operating company. 

He is motivated by the industry’s unique capability to drive value for patients and society through medicine innovation. This has driven his professional focus at the interface of commercial and Research & Development. He previously joined ViiV healthcare in 2014 as Global Commercial Lead for the long-acting Injectables that today form a critical part of ViiV’s vision for ending the epidemic.

Rob relocated to Singapore in 2017 as General Manager, leading GSK’s business there, before joining the global mission against antimicrobial resistance (AMR) in his capacity as Medicine Commercialisation Leader for GSK’s novel antibiotic portfolio. He was instrumental in progressing GSK’s internal pipeline and expanding the portfolio through in-licensing transactions. Rob then led GSK’s General Medicines Global Product Strategy Group before joining ViiV in 2024.

Robert has a first class honours degree in Biomedical Science, from the University of Sheffield, UK.

Our Executive Team

Harmony Garges, Chief Medical Officer at ViiV Healthcare
Dr Harmony Garges

Chief Medical Officer

Read more
Kimberly Smith, Head of Research and Development, ViiV Healthcare
Dr Kimberly Smith

Head of Research and Development

Read more
Lynn Baxter, Head of North America, ViiV Healthcare
Lynn Baxter

Head of North America

Read more
Neil Wilkinson, Chief Financial Officer
Neil Wilkinson

Chief Financial Officer

Read more
Robert Bowers, Head of Global Commercial Strategy, ViiV Healthcare
Robert Bowers

Head of Global Commercial Strategy

Read more
Andrew Stewart, General Counsel and Chief Compliance Officer, ViiV Healthcare
Andrew Stewart

General Counsel and Chief Compliance Officer

Read more
Stephen Rea, Head of External Affairs and Communications ViiV Healthcare
Stephen Rea

Head of External Affairs and Communications

Read more
Lauren Carey, Head of International
Lauren Carey

Head of International

Read more

YOU MAY ALSO BE INTERESTED IN

We are ViiV Healthcare: 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS.

Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.

Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.

NP-GBL-HVX-COCO-220025

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.